affiliation not provided to SSRN
Glioblastoma, In vitro models, Hydrogels, Water content, Brillouin shift, Raman intensity.
Antibody drug conjugate, Targeted delivery, TLR3 agonist, Tumor microenvironment, Vaccination in situ